Literature DB >> 19829792

Bilateral renal angiomyolipoma in a patient with tuberous sclerosis treated with resection of one kidney and transarterial embolization of other kidney using CT during selective arteriography: a case report.

Yoshiaki Katada1, Isao Umehara, Takemasa Ohki, Mitsuhiro Kishino, Hitoshi Shibuya.   

Abstract

Renal AML complicating tuberous sclerosis shows a rapid growth and its rupture is frequently associated with hemorrhagic shock as a result of profuse retroperitoneal bleeding, necessitating an aggressive therapeutic approach. This report describes the long-term clinical progress of 28 year-old woman with tuberous sclerosis with a ruptured giant AML that underwent unilateral nephrectomy, who has been followed up after treatment with concomitant application of computed tomography during selective arteriography to conserve the remaining normal renal parenchyma, and in whom the need for initiation of dialysis has been successfully avoided, with conspicuous reduction of the tumor size.

Entities:  

Year:  2009        PMID: 19829792      PMCID: PMC2740105          DOI: 10.4076/1757-1626-2-6351

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


Introduction

AML of the kidney is a benign neoplastic lesion that is composed of vascular and smooth muscle components and adipose tissue, and has come to be recognized as a rather common complication of tuberous sclerosis [1,2]. AML complicating tuberous sclerosis shows a rapid growth and its rupture is frequently associated with hemorrhagic shock as a result of profuse retroperitoneal bleeding, necessitating an aggressive therapeutic approach [1-3].

Case presentation

The patient, a 28-year-old Japanese woman, had been under periodic follow-up since her childhood for tuberous sclerosis, and underwent right nephrectomy for AML at the age of 17; she continued to be under follow-up for immediate detection of AML developing in the remaining left kidney. During the course of follow-up, the patient developed sudden abdominal pain and needed emergency hospitalization because of decreased serum Hb level. Laboratory examination at admission revealed a serum Hb level of 7.3 g/dL and serum Cre of 0.9 mg/dL. Abdominal CT revealed a fairly large-sized tumorous lesion situated primarily in the left retroperitoneum and containing a huge aneurysm-like hemorrhage. The left renal artery was dilated to nearly the size of the aorta (Figure 1A). While a part of the normal kidney parenchyma was identified (Figure 1B), most of the remaining organ was occupied by the AML and constituents of the hematoma secondary to rupture, that conspicuously impinged on and displaced the abdominal viscera (Figure 1A, Figure 1B).
Figure 1.

CT scans on admission. Abdominal CT demonstrated a fairly large-sized AML in the left retroperitoneum and containing a huge aneurysm-like hemorrhage (arrow heads). The left renal artery was dilated to nearly the size of the aorta (thick arrow). (B) A part of the normal renal parenchyma was identified (thin arrow).

CT scans on admission. Abdominal CT demonstrated a fairly large-sized AML in the left retroperitoneum and containing a huge aneurysm-like hemorrhage (arrow heads). The left renal artery was dilated to nearly the size of the aorta (thick arrow). (B) A part of the normal renal parenchyma was identified (thin arrow). An abdominal angiography revealed marked distension of the left renal artery, and it was difficult to visualize the mass clearly and to accurately delineate the vascular supplies to the normal kidney parenchyma, even by left renal arteriography (infusion rate, 7 mL/sec; total dose of the contrast medium, 35 mL) (Figure 2A). Based on these findings, we carried out embolization of the aneurysm-like bleeding site with metallic coils (Figure 2B) and of the rest of the bleeding sites with gelatin sponge particles upon identifying the blood vessels supplying the normal renal parenchyma, with concomitant CTSA (Figure 3). Angiography performed after the embolization procedure demonstrated satisfactory visualization of the normal renal parenchyma and the remaining embolized tumor vasculature (Figure 4).
Figure 2.

Left renal arteriogram. (A) The mass was poorly visualized due to the conspicuous increase of blood flow, despite injection of contrast medium even at the rate of 7 mL/sec (total dose: 35 mL). (B) An aneurysm-like hemorrhage was visualized. A pseudoaneurysm and tumor blushes are also noted.

Figure 3.

CT during selective arteriography. Most of the normal renal parenchyma can be visualized, allowing precise identification of the feeding blood vessels of the normal kidney, although there are filling defects in a part of the normal kidney.

Figure 4.

Left renal arteriogram after the embolization procedure angiography performed after the embolization procedure demonstrated satisfactory visualization of the normal renal parenchyma and the remaining embolized tumor vasculature.

Left renal arteriogram. (A) The mass was poorly visualized due to the conspicuous increase of blood flow, despite injection of contrast medium even at the rate of 7 mL/sec (total dose: 35 mL). (B) An aneurysm-like hemorrhage was visualized. A pseudoaneurysm and tumor blushes are also noted. CT during selective arteriography. Most of the normal renal parenchyma can be visualized, allowing precise identification of the feeding blood vessels of the normal kidney, although there are filling defects in a part of the normal kidney. Left renal arteriogram after the embolization procedure angiography performed after the embolization procedure demonstrated satisfactory visualization of the normal renal parenchyma and the remaining embolized tumor vasculature. At half a year and about 5 years after the embolization, CT scans showed marked contraction in the size of the tumor and hematoma, with no evidence of any fresh hemorrhage (Figure 5a, 5b, 5c, and 5d). The CT obtained at 5 years post embolization, nevertheless, demonstrated an increase in the size of the AML arising from the left kidney (Figure 5c, 5d). In regard to the renal function, the serum Cre level was 1.5 mg/dL at the time of discharge and remained practically constant thereafter, except for one instance of worsening when the patient developed septicemia of uterine origin during the 4th year post operation. The serum Cre level has remained in the 3 to 3.5 mg/dL range, and the patient has not needed initiation of dialysis therapy.
Figure 5.

CT scans at half a year (A-B) and 5 years after (C-D) the treatment (A-D) Gradual diminution of the retroperitoneal hematoma and angiomuscular components of the tumor. The conserved renal parenchyma is satisfactorily visualized. (C-D) CT performed 5 years after the treatment demonstrated disappearance of the hematoma and angiomuscular components, but enlargement of the angiomyolipoma developing from the conserved kidney (thick arrows).

CT scans at half a year (A-B) and 5 years after (C-D) the treatment (A-D) Gradual diminution of the retroperitoneal hematoma and angiomuscular components of the tumor. The conserved renal parenchyma is satisfactorily visualized. (C-D) CT performed 5 years after the treatment demonstrated disappearance of the hematoma and angiomuscular components, but enlargement of the angiomyolipoma developing from the conserved kidney (thick arrows).

Discussion

Tuberous sclerosis is frequently complicated by AML, which is known to occur more frequently as multiple lesions and to grow to larger sizes as compared with idiopathic AML. It has also been documented that AML associated with tuberous sclerosis shows a high likelihood of rupture during the clinical course, with resultant hemorrhagic shock secondary to hematuria and retroperitoneal bleeding [1-10]. In regard to transcatheter arterial embolization for the treatment of AML, Moorhead et al. [4] reported the results of embolization with gelatin sponge particles in 1977; thereafter, several investigators have reported the results of the procedure in both patients with ruptured and unruptured AML [4-8,10]. Currently, embolization represents the therapy of first choice in a significant proportion of the cases. In the present case, the attempt to delineate the whole mass by angiography was virtually unsuccessful even after injection of 35 mL of contrast medium at the rate of 7 mL/sec. Therefore, we employed CTSA, which enabled efficient differentiation between the feeding arteries to the tumor and the normal renal vasculature with the use of a smaller volume of contrast medium early after the start of treatment, and thereby, efficient embolization therapy. Marked amelioration of the abdominal compressive symptoms was also anticipated with the expected contraction of the retroperitoneal hematoma with the ruptured AML and reduction in the diameter of the tumor. We used metallic coils in this case, but the use of metallic coils calls for discretion, that is, their use should be limited solely to embolization at the site of rupture of an aneurysm, because they may not only give rise to the formation of collateral circuits to the tumor, but also cause revascularization of the metallic coil and pose a hindrance at the next intervention. Our present patient has been under periodic follow-up for over 5 years; a long-sustained contraction of the hematoma and angiomyomatous components of the tumor has been evident from the time the treatment was administered until date. Although introduction of dialysis may hardly be avoidable with possible enlargement of the AML arising from the left kidney in the future [7], its avoidance for over 5 years is considered beneficial for patients.

Conclusion

Selective embolization is recommended even in cases with rupture of a giant AML developing in a unilateral residual kidney because embolization of the tumor vasculature and the attempt to conserve normal renal parenchyma to the greatest extent possible provides not only hemostasis, but also results in reduction of the tumor diameter and conservation of renal function. In the present case, the adoption of this therapeutic strategy with concomitant CT during selective arteriography yielded favorable outcomes both in the short-term and in the long-term.
  10 in total

1.  Renal angiomyolipoma in Japanese tuberous sclerosis patients.

Authors:  Yoshihiro Kitano; Toshiro Honna; Kenji Nihei; Jun Miyauchi; Kentarou Matsuoka; Tatsuo Kuroda; Kiyoshi Tanaka; Nobuyuki Morikawa; Yasushi Fuchimoto
Journal:  J Pediatr Surg       Date:  2004-12       Impact factor: 2.545

2.  Renal angiomyolipoma: selective arterial embolization--effectiveness and changes in angiomyogenic components in long-term follow-up.

Authors:  Y M Han; J K Kim; B S Roh; H Y Song; J M Lee; Y H Lee; S Y Lee; G H Chung; C S Kim; M H Sohn; K C Choi
Journal:  Radiology       Date:  1997-07       Impact factor: 11.105

Review 3.  Therapeutic embolization for renal angiomyolipoma: case report and review of the literature.

Authors:  A Uchino; K Itoh; K Egashira; M Ohno
Journal:  Radiat Med       Date:  1987 Nov-Dec

Review 4.  The management of renal angiomyolipoma.

Authors:  J E Oesterling; E K Fishman; S M Goldman; F F Marshall
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

5.  Renal angiomyolipoma: long-term results after arterial embolization.

Authors:  Nishita Kothary; Michael C Soulen; Timothy W I Clark; A J Wein; Richard D Shlansky-Goldberg; Peter B Crino; S William Stavropoulos
Journal:  J Vasc Interv Radiol       Date:  2005-01       Impact factor: 3.464

6.  The natural history of renal angiomyolipoma.

Authors:  M S Steiner; S M Goldman; E K Fishman; F F Marshall
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

7.  Management of hemorrhage secondary to renal angiomyolipoma with selective arterial embolization.

Authors:  J D Moorhead; P Fritzsche; H L Hadley
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

8.  Embolization of renal angiomyolipoma: immediate complications and long-term outcomes.

Authors:  J Lenton; D Kessel; A F Watkinson
Journal:  Clin Radiol       Date:  2008-04-28       Impact factor: 2.350

9.  Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture.

Authors:  Koichiro Yamakado; Naoshi Tanaka; Toshio Nakagawa; Shigeki Kobayashi; Makoto Yanagawa; Kan Takeda
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

10.  Renal angiomyolipoma presenting with massive retroperitoneal haemorrhage due to deranged clotting factors: a case report.

Authors:  Timothy Wright; Prasanna Sooriakumaran
Journal:  Cases J       Date:  2008-10-04
  10 in total
  2 in total

1.  Embolization of symptomatic renal angiomyolipoma with a mixture of lipiodol and PVA, a mid-term result.

Authors:  Qiang Huang; Ren-You Zhai
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

2.  Transarterial embolization for renal angiomyolipomas: A single centre experience in 79 patients.

Authors:  Chengen Wang; Min Yang; Xiaoqiang Tong; Jian Wang; Haitao Guan; Guochen Niu; Ziguang Yan; Bihui Zhang; Yinghua Zou
Journal:  J Int Med Res       Date:  2017-01-30       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.